RU2020100475A3 - - Google Patents

Download PDF

Info

Publication number
RU2020100475A3
RU2020100475A3 RU2020100475A RU2020100475A RU2020100475A3 RU 2020100475 A3 RU2020100475 A3 RU 2020100475A3 RU 2020100475 A RU2020100475 A RU 2020100475A RU 2020100475 A RU2020100475 A RU 2020100475A RU 2020100475 A3 RU2020100475 A3 RU 2020100475A3
Authority
RU
Russia
Application number
RU2020100475A
Other languages
Russian (ru)
Other versions
RU2020100475A (ru
RU2772278C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59358204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2020100475(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2020100475A publication Critical patent/RU2020100475A/ru
Publication of RU2020100475A3 publication Critical patent/RU2020100475A3/ru
Application granted granted Critical
Publication of RU2772278C2 publication Critical patent/RU2772278C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2020100475A 2017-06-14 2018-06-25 Лечение мигрени RU2772278C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1709459.0 2017-06-14
GBGB1709459.0A GB201709459D0 (en) 2017-06-14 2017-06-14 Treatment for migraine
PCT/IB2018/054676 WO2018229738A1 (en) 2017-06-14 2018-06-25 Treatment for migraine

Publications (3)

Publication Number Publication Date
RU2020100475A RU2020100475A (ru) 2021-07-14
RU2020100475A3 true RU2020100475A3 (enExample) 2021-10-22
RU2772278C2 RU2772278C2 (ru) 2022-05-18

Family

ID=

Also Published As

Publication number Publication date
PL3638370T3 (pl) 2021-05-17
KR20210013518A (ko) 2021-02-04
SMT202100037T1 (it) 2021-03-15
ES2847169T3 (es) 2021-08-02
DK3638370T3 (da) 2021-01-25
US20200253905A1 (en) 2020-08-13
CN111093772A (zh) 2020-05-01
CN111093772B (zh) 2023-11-03
ZA201908087B (en) 2024-11-27
SI3638370T1 (sl) 2021-04-30
CY1123860T1 (el) 2022-05-27
WO2018229738A1 (en) 2018-12-20
AU2018284330B2 (en) 2024-03-14
IL271211B1 (en) 2023-09-01
MA49396B1 (fr) 2021-03-31
RU2020100475A (ru) 2021-07-14
KR102594130B1 (ko) 2023-10-24
JP7130739B2 (ja) 2022-09-05
CA3067321A1 (en) 2018-12-20
MD3638370T2 (ro) 2021-04-30
HRP20210108T1 (hr) 2021-03-19
EP3638370B1 (en) 2020-11-11
EP3638370A1 (en) 2020-04-22
JP2020526575A (ja) 2020-08-31
US11471434B2 (en) 2022-10-18
BR112019026660A2 (pt) 2020-07-14
MX387909B (es) 2025-03-19
MA49396A (fr) 2020-04-22
MX2019014784A (es) 2021-11-16
AU2018284330A1 (en) 2020-01-02
HUE053089T2 (hu) 2021-06-28
SG11201912146RA (en) 2020-01-30
PT3638370T (pt) 2021-01-26
RS61481B1 (sr) 2021-03-31
LT3638370T (lt) 2021-03-25
GB201709459D0 (en) 2017-07-26
IL271211B2 (en) 2024-01-01
IL271211A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
BR122021024397A2 (enExample)
BR122021000189A2 (enExample)
BR112020006084A8 (enExample)
BR112019008823A2 (enExample)
BR122022025811B8 (enExample)
BR122021023687A2 (enExample)
BR122021014832A2 (enExample)
BR122022003521A2 (enExample)
BR112020008820A2 (enExample)
BR102017023327A2 (enExample)
BE2017C035I2 (enExample)
BR202017016984U2 (enExample)
BR202017016924U2 (enExample)
BR102017015495A2 (enExample)
BR102017015250A2 (enExample)
BR102017014430A2 (enExample)
BR202017012548U2 (enExample)
BR202017011220U2 (enExample)
BR202017010814U2 (enExample)
BR202017010373U2 (enExample)
BR202017009870U2 (enExample)
BR202017006953U2 (enExample)
BR202017004898U2 (enExample)
BR102017003115A2 (enExample)
BR202017002937U2 (enExample)